Literature DB >> 28004168

Review of the Clinical Evidence for the Use of DEBIRI in the Treatment of Colorectal Metastatic Disease.

Shamar Young1, Donna D'Souza2, Siobhan Flanagan2, Jafar Golzarian2.   

Abstract

Colorectal cancer is a common malignancy that most commonly metastasizes to the liver. There has been considerable effort in developing new treatment options for these patients. One method that has been developed for the treatment of colorectal metastases to the liver is irinotecan-loaded drug-eluting bead (DEBIRI) embolization. This article reviews the current literature on DEBIRI and discusses the state of current knowledge and possible areas of future investigation.

Entities:  

Keywords:  Colon cancer; Drug elutting beads; Transarterial chemoembolization (TACE)

Mesh:

Substances:

Year:  2016        PMID: 28004168     DOI: 10.1007/s00270-016-1537-5

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  1 in total

1.  Chemoembolization with CalliSpheres drug-eluting beads loaded with irinotecan in the treatment of unresectable colorectal cancer liver metastases: preliminary results in 16 cases.

Authors:  Jian Kong; Yong Li; Yin-Jian Bian; Jian-Xi Guo; Yan-Fang Zhang
Journal:  Transl Cancer Res       Date:  2019-06       Impact factor: 1.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.